The Current Ratio as of November 2025 (TTM) for Qualigen Therapeutics, Inc. (QLGN) is 8.83

According to Qualigen Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.83. This represents a change of 174.22% compared to the average of 3.22 of the last 4 quarters.

Qualigen Therapeutics, Inc. (QLGN) Historical Current Ratio (quarterly & annually)

How has QLGN Current Ratio performed in the past?

The mean historical Current Ratio of Qualigen Therapeutics, Inc. over the last ten years is 2.21. The current 8.83 Current Ratio has changed 39.80% with respect to the historical average. Over the past ten years (40 quarters), QLGN's Current Ratio was at its highest in in the September 2025 quarter at 8.83. The Current Ratio was at its lowest in in the June 2024 quarter at 0.11.

Qualigen Therapeutics, Inc. (QLGN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Qualigen Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Qualigen Therapeutics, Inc. (QLGN) Average Current Ratio

How has QLGN Current Ratio performed in the past?

The current Current Ratio of Qualigen Therapeutics, Inc. (QLGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Qualigen Therapeutics, Inc. (QLGN) Current Ratio vs. Peers

How is QLGN’s Current Ratio compared to its peers?

Qualigen Therapeutics, Inc.’s Current Ratio is greater than Soligenix, Inc. (1.47), greater than Oragenics, Inc. (0.71), less than Titan Pharmaceuticals, Inc. (11.60), greater than Can-Fite BioPharma Ltd. (3.60), greater than Xenetic Biosciences, Inc. (4.56), greater than Kazia Therapeutics Limited (0.21), greater than Ensysce Biosciences, Inc. (1.27), greater than CNS Pharmaceuticals, Inc. (5.81), greater than Clearmind Medicine Inc. (1.74), greater than KALA BIO, Inc. (0.75),

Build a custom stock screener for Qualigen Therapeutics, Inc. (QLGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qualigen Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Qualigen Therapeutics, Inc. (QLGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Qualigen Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.